Table 2.

Effect of HCFP on body weight and immune organ after 14-repeated day administration in male and female Wistar rats.

Gender	Group	Body Weight Gain (g)	Spleen Index
Male	Control	78.00 ± 17.06	2.54 ± 0.32
	Low dose	101.67 ± 7.10	2.66 ± 0.20
	High dose	32.00 ± 12.73 *	3.37 ± 0.08 *
Female	Control	38.33 ± 5.86	3.38 ± 0.02
	Low dose	26.67 ± 8.51	3.15 ± 0.46
	High dose	27.67 ± 14.01	3.26 ± 0.15

Data were expressed as mean ± SD from three rats for each group of healthy rats. Control; water administration of 4 mL/kg. Low and high doses; HCFP soluble fraction administration of 3.08 and 6.16 mL/kg, respectively. * p < 0.05 indicate significant differences between treatments and control group. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparison test.